AI Coding Live News

In an Oct 27 blog post, Anthropic described months of deep research partnerships between its life sciences team and six organizations (BigHat, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group), covering hit generation, lead optimization, manufacturing paperwork and clinical trial planning. It also said it acquired the one-person company Mithril Medicine to run its own programs for rare childhood muscular dystrophy. Anthropic stresses the work is mostly preclinical so far.

Zoom

During the GTC Berlin keynote, NVIDIA unleashed a sweeping array of open-weights domain-specific foundation models. The release highlights include the multimodal Nemotron 3.5 Super VL, the lightweight Nemotron 3.5 Bolt series, and the end-to-end Nemotron Retriever suite for embedding, reranking, and document OCR. For physical AI, NVIDIA debuted the Cosmos world models and Alpamayo 2 Edge autonomous driving models. In life sciences, NVIDIA and the Baker Lab released BioNeMo RFD4-Proteina, which establishes state-of-the-art accuracy across more than 10 protein design benchmarks while synthesizing 200-amino-acid binders roughly 13x faster than RFdiffusion3.

Zoom

Anthropic (@AnthropicAI) announced that Claude has autonomously discovered a previously unknown enzyme system in bacterial DNA, termed Array-Associated Reverse Transcriptase (ART). Operating alongside CRISPR-like repeats, ART represents a novel RNA-directed genome modification mechanism and marks the first major discovery from Anthropic's dedicated wet lab and life sciences team.

Zoom